Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody.

Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody.

Item
http://www.wikidata.org/entity/Q30420907
Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approachImproved Stability of a Model IgG3 by DoE-Based Evaluation of Buffer FormulationsUnderstanding pharmaceutical quality by designAccelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools.Continuous downstream processing for high value biological products: A Review.Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stress.Using simple models to describe the kinetics of growth, glucose consumption, and monoclonal antibody formation in naive and infliximab producer CHO cells.High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations.Predicting protein-protein interactions of concentrated antibody solutions using dilute solution data and coarse-grained molecular models.A step forward towards the development of stable freeze-dried liposomes: a quality by design approach (QbD).
P2860

Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody.

Item
http://www.wikidata.org/entity/Q30420907
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Quality by design: impact of f ...... ophilized monoclonal antibody.
@ast
Quality by design: impact of f ...... ophilized monoclonal antibody.
@en
type
label
Quality by design: impact of f ...... ophilized monoclonal antibody.
@ast
Quality by design: impact of f ...... ophilized monoclonal antibody.
@en
prefLabel
Quality by design: impact of f ...... ophilized monoclonal antibody.
@ast
Quality by design: impact of f ...... ophilized monoclonal antibody.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Quality by design: impact of f ...... ophilized monoclonal antibody.
@en
P2093
P304
P31
P356
10.1016/J.IJPHARM.2012.08.033
P407
P433
P478
P577
P698
P921